Research Insight LLC
15
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
47%
7 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
Role: lead
The THINK Study Incidence of Neurotrophic Keratopathy)
Role: lead
2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
Role: lead
The COAT Trial: Cequa's Onset of Action Trial
Role: lead
The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction
Role: lead
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
Role: lead
Evaluation of the Accuracy & Safety of the LaserArcs Nomogram
Role: lead
The DEPOT Study (Dry Eye Prescription Options for Therapy)
Role: lead
The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study
Role: lead
Veracity Surgical: A Time/Motion and Quality of Care Study
Role: lead
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
Role: lead
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
Role: lead
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
Role: lead
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
Role: lead
Comparison of Pre-operative Measurements With Intraoperative Aberrometry in Predicting Correction for Low Toric Lens Correction in Cataract Surgery
Role: lead
All 15 trials loaded